IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. (Q40618350)
Jump to navigation
Jump to search
scientific article published on November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. |
scientific article published on November 2003 |
Statements
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2 (English)
Bruce W S Robinson
Christine S Bundell
Beverley F Kinnear
Alison M Smith
Pierre Filion
Deborah van Hagen
Delia J Nelson
1 November 2003